table of content
1 Introduction to Research & Analysis Reports
1.1 Urinary System Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Urinary System Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Urinary System Drugs Overall Market Size
2.1 Global Urinary System Drugs Market Size: 2022 VS 2030
2.2 Global Urinary System Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Urinary System Drugs Players in Global Market
3.2 Top Global Urinary System Drugs Companies Ranked by Revenue
3.3 Global Urinary System Drugs Revenue by Companies
3.4 Top 3 and Top 5 Urinary System Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Urinary System Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Urinary System Drugs Players in Global Market
3.6.1 List of Global Tier 1 Urinary System Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Urinary System Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Urinary System Drugs Market Size Markets, 2022 & 2030
4.1.2 Injection
4.1.3 Tablets
4.1.4 Capsule
4.1.5 Suppository
4.1.6 Granules
4.1.7 Powder
4.1.8 Pills
4.1.9 Cream
4.1.10 Others
4.2 By Type - Global Urinary System Drugs Revenue & Forecasts
4.2.1 By Type - Global Urinary System Drugs Revenue, 2018-2023
4.2.2 By Type - Global Urinary System Drugs Revenue, 2024-2030
4.2.3 By Type - Global Urinary System Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Urinary System Drugs Market Size, 2022 & 2030
5.1.2 Kidney Disease Medication
5.1.3 Medication For Prostate Disease
5.1.4 Male Dysfunction
5.1.5 Lithotripsy Drug
5.1.6 Others
5.2 By Application - Global Urinary System Drugs Revenue & Forecasts
5.2.1 By Application - Global Urinary System Drugs Revenue, 2018-2023
5.2.2 By Application - Global Urinary System Drugs Revenue, 2024-2030
5.2.3 By Application - Global Urinary System Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Urinary System Drugs Market Size, 2022 & 2030
6.2 By Region - Global Urinary System Drugs Revenue & Forecasts
6.2.1 By Region - Global Urinary System Drugs Revenue, 2018-2023
6.2.2 By Region - Global Urinary System Drugs Revenue, 2024-2030
6.2.3 By Region - Global Urinary System Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Urinary System Drugs Revenue, 2018-2030
6.3.2 US Urinary System Drugs Market Size, 2018-2030
6.3.3 Canada Urinary System Drugs Market Size, 2018-2030
6.3.4 Mexico Urinary System Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Urinary System Drugs Revenue, 2018-2030
6.4.2 Germany Urinary System Drugs Market Size, 2018-2030
6.4.3 France Urinary System Drugs Market Size, 2018-2030
6.4.4 U.K. Urinary System Drugs Market Size, 2018-2030
6.4.5 Italy Urinary System Drugs Market Size, 2018-2030
6.4.6 Russia Urinary System Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Urinary System Drugs Market Size, 2018-2030
6.4.8 Benelux Urinary System Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Urinary System Drugs Revenue, 2018-2030
6.5.2 China Urinary System Drugs Market Size, 2018-2030
6.5.3 Japan Urinary System Drugs Market Size, 2018-2030
6.5.4 South Korea Urinary System Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Urinary System Drugs Market Size, 2018-2030
6.5.6 India Urinary System Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Urinary System Drugs Revenue, 2018-2030
6.6.2 Brazil Urinary System Drugs Market Size, 2018-2030
6.6.3 Argentina Urinary System Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Urinary System Drugs Revenue, 2018-2030
6.7.2 Turkey Urinary System Drugs Market Size, 2018-2030
6.7.3 Israel Urinary System Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Urinary System Drugs Market Size, 2018-2030
6.7.5 UAE Urinary System Drugs Market Size, 2018-2030
7 Urinary System Drugs Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Urinary System Drugs Major Product Offerings
7.1.4 Johnson & Johnson Urinary System Drugs Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Urinary System Drugs Major Product Offerings
7.2.4 Bayer Urinary System Drugs Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Urinary System Drugs Major Product Offerings
7.3.4 Pfizer Urinary System Drugs Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 GSK
7.4.1 GSK Company Summary
7.4.2 GSK Business Overview
7.4.3 GSK Urinary System Drugs Major Product Offerings
7.4.4 GSK Urinary System Drugs Revenue in Global Market (2018-2023)
7.4.5 GSK Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Urinary System Drugs Major Product Offerings
7.5.4 Boehringer Ingelheim Urinary System Drugs Revenue in Global Market (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Urinary System Drugs Major Product Offerings
7.6.4 Roche Urinary System Drugs Revenue in Global Market (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Urinary System Drugs Major Product Offerings
7.7.4 Novartis Urinary System Drugs Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Urinary System Drugs Major Product Offerings
7.8.4 AstraZeneca Urinary System Drugs Revenue in Global Market (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Dr. Reddy?s Laboratories
7.9.1 Dr. Reddy?s Laboratories Company Summary
7.9.2 Dr. Reddy?s Laboratories Business Overview
7.9.3 Dr. Reddy?s Laboratories Urinary System Drugs Major Product Offerings
7.9.4 Dr. Reddy?s Laboratories Urinary System Drugs Revenue in Global Market (2018-2023)
7.9.5 Dr. Reddy?s Laboratories Key News & Latest Developments
7.10 Mylan
7.10.1 Mylan Company Summary
7.10.2 Mylan Business Overview
7.10.3 Mylan Urinary System Drugs Major Product Offerings
7.10.4 Mylan Urinary System Drugs Revenue in Global Market (2018-2023)
7.10.5 Mylan Key News & Latest Developments
7.11 Sun Pharma
7.11.1 Sun Pharma Company Summary
7.11.2 Sun Pharma Business Overview
7.11.3 Sun Pharma Urinary System Drugs Major Product Offerings
7.11.4 Sun Pharma Urinary System Drugs Revenue in Global Market (2018-2023)
7.11.5 Sun Pharma Key News & Latest Developments
7.12 Cipla
7.12.1 Cipla Company Summary
7.12.2 Cipla Business Overview
7.12.3 Cipla Urinary System Drugs Major Product Offerings
7.12.4 Cipla Urinary System Drugs Revenue in Global Market (2018-2023)
7.12.5 Cipla Key News & Latest Developments
7.13 Merck
7.13.1 Merck Company Summary
7.13.2 Merck Business Overview
7.13.3 Merck Urinary System Drugs Major Product Offerings
7.13.4 Merck Urinary System Drugs Revenue in Global Market (2018-2023)
7.13.5 Merck Key News & Latest Developments
7.14 Cubist Pharmaceuticals
7.14.1 Cubist Pharmaceuticals Company Summary
7.14.2 Cubist Pharmaceuticals Business Overview
7.14.3 Cubist Pharmaceuticals Urinary System Drugs Major Product Offerings
7.14.4 Cubist Pharmaceuticals Urinary System Drugs Revenue in Global Market (2018-2023)
7.14.5 Cubist Pharmaceuticals Key News & Latest Developments
7.15 Abbott Laboratories
7.15.1 Abbott Laboratories Company Summary
7.15.2 Abbott Laboratories Business Overview
7.15.3 Abbott Laboratories Urinary System Drugs Major Product Offerings
7.15.4 Abbott Laboratories Urinary System Drugs Revenue in Global Market (2018-2023)
7.15.5 Abbott Laboratories Key News & Latest Developments
7.16 Eli Lilly
7.16.1 Eli Lilly Company Summary
7.16.2 Eli Lilly Business Overview
7.16.3 Eli Lilly Urinary System Drugs Major Product Offerings
7.16.4 Eli Lilly Urinary System Drugs Revenue in Global Market (2018-2023)
7.16.5 Eli Lilly Key News & Latest Developments
7.17 Melinta Therapeutics
7.17.1 Melinta Therapeutics Company Summary
7.17.2 Melinta Therapeutics Business Overview
7.17.3 Melinta Therapeutics Urinary System Drugs Major Product Offerings
7.17.4 Melinta Therapeutics Urinary System Drugs Revenue in Global Market (2018-2023)
7.17.5 Melinta Therapeutics Key News & Latest Developments
7.18 Sanofi
7.18.1 Sanofi Company Summary
7.18.2 Sanofi Business Overview
7.18.3 Sanofi Urinary System Drugs Major Product Offerings
7.18.4 Sanofi Urinary System Drugs Revenue in Global Market (2018-2023)
7.18.5 Sanofi Key News & Latest Developments
7.19 Daiichi Sankyo
7.19.1 Daiichi Sankyo Company Summary
7.19.2 Daiichi Sankyo Business Overview
7.19.3 Daiichi Sankyo Urinary System Drugs Major Product Offerings
7.19.4 Daiichi Sankyo Urinary System Drugs Revenue in Global Market (2018-2023)
7.19.5 Daiichi Sankyo Key News & Latest Developments
7.20 Lupin
7.20.1 Lupin Company Summary
7.20.2 Lupin Business Overview
7.20.3 Lupin Urinary System Drugs Major Product Offerings
7.20.4 Lupin Urinary System Drugs Revenue in Global Market (2018-2023)
7.20.5 Lupin Key News & Latest Developments
7.21 Apogepha
7.21.1 Apogepha Company Summary
7.21.2 Apogepha Business Overview
7.21.3 Apogepha Urinary System Drugs Major Product Offerings
7.21.4 Apogepha Urinary System Drugs Revenue in Global Market (2018-2023)
7.21.5 Apogepha Key News & Latest Developments
7.22 Astellas Pharma
7.22.1 Astellas Pharma Company Summary
7.22.2 Astellas Pharma Business Overview
7.22.3 Astellas Pharma Urinary System Drugs Major Product Offerings
7.22.4 Astellas Pharma Urinary System Drugs Revenue in Global Market (2018-2023)
7.22.5 Astellas Pharma Key News & Latest Developments
7.23 Dr. Dunner
7.23.1 Dr. Dunner Company Summary
7.23.2 Dr. Dunner Business Overview
7.23.3 Dr. Dunner Urinary System Drugs Major Product Offerings
7.23.4 Dr. Dunner Urinary System Drugs Revenue in Global Market (2018-2023)
7.23.5 Dr. Dunner Key News & Latest Developments
7.24 Kowa
7.24.1 Kowa Company Summary
7.24.2 Kowa Business Overview
7.24.3 Kowa Urinary System Drugs Major Product Offerings
7.24.4 Kowa Urinary System Drugs Revenue in Global Market (2018-2023)
7.24.5 Kowa Key News & Latest Developments
7.25 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
7.25.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Summary
7.25.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Business Overview
7.25.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Major Product Offerings
7.25.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Revenue in Global Market (2018-2023)
7.25.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Key News & Latest Developments
7.26 Tianjin Tongrentang Group
7.26.1 Tianjin Tongrentang Group Company Summary
7.26.2 Tianjin Tongrentang Group Business Overview
7.26.3 Tianjin Tongrentang Group Urinary System Drugs Major Product Offerings
7.26.4 Tianjin Tongrentang Group Urinary System Drugs Revenue in Global Market (2018-2023)
7.26.5 Tianjin Tongrentang Group Key News & Latest Developments
7.27 Jiangsu Hengrui Pharmaceutical
7.27.1 Jiangsu Hengrui Pharmaceutical Company Summary
7.27.2 Jiangsu Hengrui Pharmaceutical Business Overview
7.27.3 Jiangsu Hengrui Pharmaceutical Urinary System Drugs Major Product Offerings
7.27.4 Jiangsu Hengrui Pharmaceutical Urinary System Drugs Revenue in Global Market (2018-2023)
7.27.5 Jiangsu Hengrui Pharmaceutical Key News & Latest Developments
7.28 Hunan Qianjin Xiang River Pharmaceutical
7.28.1 Hunan Qianjin Xiang River Pharmaceutical Company Summary
7.28.2 Hunan Qianjin Xiang River Pharmaceutical Business Overview
7.28.3 Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Major Product Offerings
7.28.4 Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Revenue in Global Market (2018-2023)
7.28.5 Hunan Qianjin Xiang River Pharmaceutical Key News & Latest Developments
7.29 Kunming Jida Pharmaceutical
7.29.1 Kunming Jida Pharmaceutical Company Summary
7.29.2 Kunming Jida Pharmaceutical Business Overview
7.29.3 Kunming Jida Pharmaceutical Urinary System Drugs Major Product Offerings
7.29.4 Kunming Jida Pharmaceutical Urinary System Drugs Revenue in Global Market (2018-2023)
7.29.5 Kunming Jida Pharmaceutical Key News & Latest Developments
7.30 Jiangsu Lianhuan Pharmaceutical
7.30.1 Jiangsu Lianhuan Pharmaceutical Company Summary
7.30.2 Jiangsu Lianhuan Pharmaceutical Business Overview
7.30.3 Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Major Product Offerings
7.30.4 Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Revenue in Global Market (2018-2023)
7.30.5 Jiangsu Lianhuan Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
